Literature DB >> 20650055

Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia.

D Carcione1, C Giele, L S Goggin, K S Kwan, D W Smith, G K Dowse, D B Mak, P Effler.   

Abstract

We conducted a prospective household transmission study to examine whether receipt of 2009 trivalent influenza vaccine (TIV) was associated with increased risk of influenza-like illness (ILI) among contacts of confirmed pandemic influenza A(H1N1) 2009 patients. In the week following onset of pandemic illness in a household member, 46 (15%) of 304 TIV-vaccinated contacts, and 174 (15%) of 1,162 unvaccinated contacts developed ILI (p=0.95). Receipt of 2009 TIV had no effect on one's risk of pandemic illness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650055

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  9 in total

Review 1.  Household transmission of 2009 pandemic influenza A (H1N1): a systematic review and meta-analysis.

Authors:  Lincoln L H Lau; Hiroshi Nishiura; Heath Kelly; Dennis K M Ip; Gabriel M Leung; Benjamin J Cowling
Journal:  Epidemiology       Date:  2012-07       Impact factor: 4.822

Review 2.  Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses.

Authors:  Zhi-yuan Li; Jin-yan Chen; Yan-ling Zhang; Wei-ming Fu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers.

Authors:  Ben Hudson; Les Toop; Dee Mangin; Cheryl Brunton; Lance Jennings; Lynn Fletcher
Journal:  Br J Gen Pract       Date:  2013-06       Impact factor: 5.386

4.  Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Authors:  Wiebke Hellenbrand; Pernille Jorgensen; Brunhilde Schweiger; Gerhard Falkenhorst; Matthias Nachtnebel; Benedikt Greutélaers; Christian Traeder; Ole Wichmann
Journal:  BMC Infect Dis       Date:  2012-05-31       Impact factor: 3.090

5.  Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.

Authors:  Camille Pelat; Alessandra Falchi; Fabrice Carrat; Anne Mosnier; Isabelle Bonmarin; Clément Turbelin; Sophie Vaux; Sylvie van der Werf; Jean Marie Cohen; Bruno Lina; Thierry Blanchon; Thomas Hanslik
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

6.  No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.

Authors:  Salaheddin M Mahmud; Paul Van Caeseele; Gregory Hammond; Carol Kurbis; Tim Hilderman; Lawrence Elliott
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

7.  Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.

Authors:  Gerardo Chowell; Santiago Echevarría-Zuno; Cécile Viboud; Lone Simonsen; Mark A Miller; Irma Fernández-Gárate; Cesar González-Bonilla; Víctor H Borja-Aburto
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

Review 8.  Immune History and Influenza Vaccine Effectiveness.

Authors:  Joseph A Lewnard; Sarah Cobey
Journal:  Vaccines (Basel)       Date:  2018-05-21

9.  Occurrence of AH1N1 viral infection and clinical features in symptomatic patients who received medical care during the 2009 influenza pandemic in Central Mexico.

Authors:  Juan Pablo Castillo-Palencia; Lucie Laflamme; Joel Monárrez-Espino
Journal:  BMC Infect Dis       Date:  2012-12-20       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.